Anoro ellipta and Hallucinations - a phase IV clinical study of FDA data

Summary:

Hallucinations is reported as a side effect among people who take Anoro ellipta (umeclidinium bromide; vilanterol trifenatate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Nuplazid, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Hallucinations when taking Anoro ellipta. It is created by eHealthMe based on reports of 16,408 people who have side effects when taking Anoro ellipta from the FDA, and is updated regularly.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,515 Anoro ellipta users. Check the latest studies of Anoro ellipta.

What is Hallucinations?

Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,891 drugs and 2,728 conditions by eHealthMe. Check the latest studies of Hallucinations.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

16,408 people reported to have side effects when taking Anoro ellipta.
Among them, 38 people (0.23%) have Hallucinations.

Could Anoro ellipta cause Hallucinations?

Among these 38 people:

How long have people been on Anoro ellipta when they have Hallucinations? *

What is the gender of people who have Hallucinations when taking Anoro ellipta? *

female: 17.65 %
male: 82.35 %

What is the age of people who have Hallucinations when taking Anoro ellipta? *

What are other drugs people take besides Anoro ellipta? *

What are other side effects people have besides Hallucinations? *

Weakness: 13 people, 34.21%
Nausea (feeling of having an urge to vomit): 10 people, 26.32%
Drowsiness: 10 people, 26.32%
Headache (pain in head): 8 people, 21.05%
Visual Acuity Reduced (reduced clearness of vision): 8 people, 21.05%
Urination - Painful: 8 people, 21.05%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 8 people, 21.05%
Muscle Aches (muscle pain): 8 people, 21.05%
Constipation: 6 people, 15.79%
Insomnia (sleeplessness): 6 people, 15.79%

What are the existing conditions these people have? *

Parkinson's Disease: 11 people, 28.95%
Gastric Ulcer Helicobacter (ulcer caused by helicobacter bacteria): 8 people, 21.05%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 18.42%
Delusion (a false belief or opinion): 5 people, 13.16%
Hiv Infection: 3 people, 7.89%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 5.26%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 5.26%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 2.63%
Stress And Anxiety: 1 person, 2.63%
Rickets (softening of bones): 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Anoro ellipta and have Hallucinations?

- Check whether Hallucinations is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anoro ellipta:

Anoro ellipta (16,515 reports)

Hallucinations treatments and more:

Hallucinations (98,683 reports)

How severe was Hallucinations and when was it recovered:

Hallucinations in Anoro ellipta

Expand to all the drugs that have ingredients of umeclidinium bromide; vilanterol trifenatate:

Hallucinations and drugs with ingredients of umeclidinium bromide; vilanterol trifenatate (42 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucinations:

Hallucinations (1,891 drugs)

Browse all the conditions that are associated with Hallucinations:

Hallucinations (2,728 conditions)

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on umeclidinium bromide; vilanterol trifenatate (the active ingredients of Anoro ellipta) and Anoro ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.